Today: 21 May 2026
Browse Category

NYSE:MRP 25 November 2025 - 30 November 2025

Lennar Stock (LEN): Exchange Offer Wraps, CEO Transition Looms as Wall Street Braces for Q4 2025 Earnings

Lennar Stock (LEN): Exchange Offer Wraps, CEO Transition Looms as Wall Street Braces for Q4 2025 Earnings

Lennar shares closed at $131.30 on November 28, down more than 20% from a recent 52-week high. The company completed an oversubscribed exchange offer, distributing 33.3 million Millrose Properties shares in return for 8 million Lennar shares. Major investors including Berkshire Hathaway have increased stakes, while Wall Street maintains a “Hold” rating. Lennar faces lower profit expectations and the retirement of Co-CEO Jon Jaffe.
Lennar (LEN) Stock: What to Watch Before the November 28, 2025 Market Open

Lennar (LEN) Stock: What to Watch Before the November 28, 2025 Market Open

Lennar completed a major share-exchange with Millrose Properties, retiring about 8 million Lennar shares after an oversubscribed offer. Lennar stock closed at $131 on November 26, up 14% in recent weeks. The company’s market cap stands near $34 billion, with institutional investors holding 81% of shares. Leadership changes and easing mortgage rates come as demand remains sensitive to affordability.
Lennar (LEN) Stock Jumps 6.6% as Millrose Exchange Offer Nears Finish Line — November 25, 2025 Update

Lennar (LEN) Stock Jumps 6.6% as Millrose Exchange Offer Nears Finish Line — November 25, 2025 Update

Lennar shares jumped 6.6% to $131.06 Tuesday, closing up $8.10 after the company’s Millrose Properties exchange offer was declared oversubscribed. Trading volume reached nearly 12 million, triple the average. Lennar will accept about 8 million tendered shares, exchanging them for 33.3 million Millrose shares at a 4.1367-to-1 ratio. Only 7.97% of tendered shares are expected to be accepted.
Lennar (LEN) Soars on Heavy Volume as Millrose Exchange Offer Deadline Hits – Stock News for November 25, 2025

Lennar (LEN) Soars on Heavy Volume as Millrose Exchange Offer Deadline Hits – Stock News for November 25, 2025

Lennar shares jumped about 5.5% to $129.70 Tuesday on volume nearly 80% above average, as investors rushed to meet the deadline for its oversubscribed Millrose Properties exchange offer. Only 8.05 million Lennar shares will be accepted from over 91.9 million tendered, with final proration set after today’s 5 p.m. ET paperwork cutoff. Millrose shares rose 3.1%.
25 November 2025

Stock Market Today

  • EnerSys Q1 CY2026 Sales Beat Estimates with Optimistic Guidance
    May 20, 2026, 6:18 PM EDT. Battery maker EnerSys (NYSE:ENS) reported Q1 CY2026 sales of $988 million, up 1.4% year on year, beating analyst estimates by 1.5%. Adjusted earnings per share (EPS) stood at $3.19, a 6.6% beat over consensus. Guidance for Q2 revenue is $935 million, 2.2% above estimates, with adjusted EPS guidance also exceeding forecasts. Despite a 6% decline in sales volumes, revenue growth was supported by price increases. Free cash flow turned negative at -$12.66 million, down from $105 million last year. EnerSys continues to push its lithium data center and battery energy storage system solutions, signaling long-term innovation. The company's subdued 4.7% annualized revenue growth over five years contrasts with sector expectations, raising caution among investors.

Latest articles

AEVEX Stock Jumps After Hours as Drone Maker Posts 307% Revenue Surge and New Air Force Deal

AEVEX Stock Jumps After Hours as Drone Maker Posts 307% Revenue Surge and New Air Force Deal

21 May 2026
AEVEX Corp. shares surged over 10% after hours Wednesday following a first-quarter profit of $21 million and new U.S. Air Force contracts worth $15.6 million. Revenue jumped to $216.7 million, beating estimates. The company, which went public in April, raised its full-year revenue outlook to $600–$620 million. The stock had closed regular trading at $26.27, down 0.23%.
Jupiter Neurosciences Stock Swings on $100M MDMA Pact, $2M Equity Sale

Jupiter Neurosciences Stock Swings on $100M MDMA Pact, $2M Equity Sale

21 May 2026
Jupiter Neurosciences shares fell 37% to $0.205 Wednesday after announcing a proposed U.S. licensing deal for PharmAla Biotech’s MDMA-based ALA-002 and a $2 million stock offering. Trading volume topped 230 million shares. The licensing agreement is non-binding, with a potential value over $100 million, and gives Jupiter 90 days to finalize terms. Jupiter reported a $2.06 million Q1 net loss and $2.36 million in cash.
Urban Outfitters Stock Swings After Record Q1—What Nuuly and Tariffs Are Telling Investors

Urban Outfitters Stock Swings After Record Q1—What Nuuly and Tariffs Are Telling Investors

21 May 2026
Urban Outfitters posted record first-quarter net income of $115.7 million and sales of $1.48 billion, beating analyst estimates. Shares closed up 4.05% at $71.67 before slipping to $70.55 in after-hours trading. Comparable retail sales rose 5.6%, with strong gains at FP Group, Urban Outfitters, and Nuuly. Gross profit rate edged down to 36.6% as tariffs pressured costs.
Go toTop